AMSTERDAM · EST. 2026
Onpeps
PEPTIDE DECISION INTELLIGENCE
Subscribe
← PEPTIDE LIBRARY
IMMUNEGRADE BPROMISING, LIMITED HUMAN DATA

LL-37

Cathelicidin antimicrobial peptide

The only human cathelicidin antimicrobial peptide, part of innate immune defence. Extensively characterised in immunology research; therapeutic use in humans remains investigational.

ALSO KNOWN AS Cathelicidin · hCAP18
REGULATORY STATUS · RESEARCH COMPOUND

Research compound — not approved for human use. Compounds in this category have not been approved for human use; availability is typically restricted to laboratory research.

§ EVIDENCE BASE
2,546
PUBLICATIONS
indexed in PubMed
20
REGISTERED TRIALS
listing it as an intervention
6
PHASE 2–4 TRIALS
reached later-stage testing
MECHANISMCathelicidin antimicrobial peptide
CATEGORYImmune
EVIDENCE GRADEB — Promising, limited human data
STATUSResearch compound — not approved for human use
COUNTS RETRIEVED2026-07-23 · re-run the PubMed query
§ RELATED COMPOUNDS
IMMUNEB
Thymosin Alpha-1
Immune modulator (T-cell maturation)
NOT MEDICAL ADVICE

This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.

THE WEEKLY BRIEF

Peptide intelligence, every Monday.

One concise email: the newest research, evidence updates, and quality signals — no hype, no spam.

Onpeps

Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.

EXPLORE
FOLLOW
PEPTIDE INFORMATION YOU CAN VERIFY© 2026 ONPEPS · AMSTERDAM, NETHERLANDS · NOT MEDICAL ADVICE